Filter
1048
Text search:
country
health
profile
Featured
Recommendations
71
New Publications
301
Language
Document type
No document type
617
Studies & Reports
187
Guidelines
105
Strategic & Response Plan
49
Manuals
36
Fact sheets
21
Training Material
13
Situation Updates
13
Resource Platforms
5
Brochures
1
Infographics
1
Countries / Regions
India
43
Global
38
Kenya
35
Malawi
26
Myanmar / Burma
25
Ethiopia
24
Nepal
23
Rwanda
23
Ghana
20
South Africa
20
Sierra Leone
19
Uganda
19
Western and Central Europe
19
Nigeria
18
Zambia
16
Tanzania
16
Syria
15
Bangladesh
15
Zimbabwe
13
Latin America and the Carribbean
13
Ukraine
12
Africa
12
Senegal
11
Indonesia
11
Namibia
11
Lesotho
11
Liberia
10
Philippines
10
Eastern Europe
10
South–East Asia Region
9
Congo, Democratic Republic of
8
Venezuela
8
South Sudan
7
Afghanistan
7
Mozambique
7
Pakistan
6
Eswatini/ Swaziland
6
Brazil
6
Cambodia
5
Botswana
5
Asia
5
Guinea
4
Burkina Faso
4
Haiti
4
Somalia
4
Thailand
4
Madagascar
4
Sri Lanka
4
Yemen
4
East and Southern Africa
4
West and Central Africa
4
Sudan
3
Hungary
3
Colombia
3
Russia
3
Cameroon
2
Lebanon
2
Papua New Guinea
2
Benin
2
Argentina
2
North Macedonia
2
Eastern Europe and Central Asia
2
Paraguay
2
Poland
2
Tajikistan
2
Moldova
2
Kazakhstan
2
Belarus
2
Mali
1
Morocco
1
Niger
1
Iraq
1
Germany
1
Turkey
1
Peru
1
Croatia
1
Ecuador
1
Bolivia
1
Mexico
1
Middle East and North Africa
1
Bhutan
1
Albania
1
Laos
1
Canada
1
Timor Leste/ East Timor
1
Romania
1
Iran
1
Kyrgyzstan
1
Georgia
1
Gabon
1
Jamaica
1
Denmark
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
470
Key Resources
75
Clinical Guidelines
73
Public Health
63
Women & Child Health
39
Capacity Building
14
Pharmacy & Technologies
11
Toolboxes
TB
72
HIV
70
Mental Health
55
COVID-19
55
Disability
41
AMR
36
Planetary Health
34
NCDs
31
Conflict
27
NTDs
25
Rapid Response
22
Pharmacy
21
Global Health Education
18
Refugee
17
Caregiver
14
Natural Hazards
12
Ebola & Marburg
11
2.0 Rapid Response
11
Polio
9
Zika
6
Health Financing Toolbox
6
Malaria
5
Cholera
3
Specific Hazards
3
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll
...
One of the first steps in developing a multisectoral action plan (MSAP) is to use a situation analysis to provide a comprehensive assessment of the health needs, prevailing risks and the context of the area to which the plan will apply. This will h
...
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
There is no guarantee that a successful pilot program introducing a reproductive health innovation can also be expanded successfully to the national or regional level, because the scaling-up process is complex and multilayered. This article describe
...
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
This action plan is intended for senior-level decision-makers in ministries of health, malaria
programme managers, entomologists, and epidemiologists working on malaria and other vectorborne diseases programmes. It is also intended for decision-mak
...
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the di
...
Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
A manual for programme managers.
The End TB Strategie
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the op
...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
